American Century Companies Inc Arrowhead Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $160,931 - $293,082	-5,791 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$39.62 - $69.97 $285,065 - $503,434	-7,195 Reduced 55.41%	5,791 $266,000
Q4 2021 Feb 07, 2022	BUY	$58.09 - $82.51 $85,624 - $121,619	1,474 Added 12.8%	12,986 $861,000
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $74,668 - $108,663	1,279 Added 12.5%	11,512 $719,000
Q2 2021 Aug 05, 2021	BUY	$62.15 - $90.32 $32,007 - $46,514	515 Added 5.3%	10,233 $847,000
Q1 2021 May 14, 2021	BUY	$61.35 - $90.47 $153,620 - $226,536	2,504 Added 34.71%	9,718 $644,000
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $33,347 - $64,966	761 Added 11.79%	7,214 $554,000
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $23,844 - $36,811	718 Added 12.52%	6,453 $278,000
Q2 2020 Aug 13, 2020	SELL	$26.12 - $43.27 $704,613 - $1.17 Million	-26,976 Reduced 82.47%	5,735 $248,000
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $43,977 - $135,013	2,139 Added 7.0%	32,711 $941,000
Q4 2019 Feb 12, 2020	SELL	$28.14 - $73.01 $2.72 Million - $7.06 Million	-96,723 Reduced 75.98%	30,572 $1.94 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $1.4 Million - $1.86 Million	-53,398 Reduced 29.55%	127,295 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $2.2 Million - $3.64 Million	126,152 Added 231.3%	180,693 $4.79 Million
Q1 2019 May 14, 2019	BUY	$12.05 - $20.18 $657,219 - $1.1 Million	54,541 New	54,541 $0

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.